A 5-YEAR CONTROLLED STUDY OF B.C.G. AND RADIOTHERAPY FOR INOPERABLE LUNG CANCER
- 1 February 1976
- journal article
- research article
- Published by Elsevier in The Lancet
- Vol. 307 (7956), 380-381
- https://doi.org/10.1016/s0140-6736(76)90213-0
Abstract
No abstract availableThis publication has 13 references indexed in Scilit:
- Extraction and preliminary characterization of a human bronchogenic carcinoma antigenBritish Journal of Cancer, 1975
- Quantitative studies of translymphnodal passage of tumour cells naturally disseminated from a non-immunogenic murine squamous carcinomaBritish Journal of Cancer, 1975
- The prognostic significance of dhs skin tests in patients with carcinoma of bronchusCancer, 1974
- ACTIVE IMMUNOTHERAPY WITH B.C.G. FOR RECURRENT MALIGNANT MELANOMAThe Lancet, 1973
- Methotrexate plus bacillus Calmette-Guérin (BCG) and isoniazid in the treatment of cancer of the head and neckThe American Journal of Surgery, 1972
- Immunotherapy of Myeloid Leukemia.Annals of Internal Medicine, 1972
- Immunological Effects of BCG in Malignant Melanoma: Two Modes of Administration ComparedAnnals of Internal Medicine, 1972
- Active Immunotherapy with Corynebacterium parvum and Chemotherapy in Murine FibrosarcomasBMJ, 1970
- Approaches to the immunological treatment of cancer in man.BMJ, 1969
- Immunologic alterations in bronchogenic cancer.Sequential StudyCancer, 1968